Developer docs
API playgroundTry for free, no card

Search company profiles

MEDA Pharma

Full company profile

uuid000inrl

Namestring
MEDA Pharma
Legal namestring
MEDA Pharma GmbH & Co.KG
Websiteurl
medapharma.de
Company typeenum
Private
Founded yearint
1919
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBad Homburg, Germany
HQ citystring
Bad Homburg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical products, prescription medicines, generic drugs, over-the-counter medicines, vaccines biosimilars
Industry4 codes
1Primary Care & General Medicine Pharmaceuticals
CodeHLAIAAAAPrimaryYes
2Generic Hospital & Institutional Products
CodeHLAIABALPrimaryNo
3Specialty Pharmacies (Complex/High-Cost Therapies)
CodeHLAFALACPrimaryNo
4Prescription Pharmaceutical (Rx) Wholesale Distribution
CodeCRAOAHAAPrimaryNo
NAICS code4 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Biological Product (except Diagnostic) Manufacturing325414
  • Pharmacies and Drug Retailers456110
  • Pharmaceutical and Medicine Manufacturing3254
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Biological Products, (No Disgnostic Substances)2836
Product category
Pharmaceutical Manufacturing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeHardware Sales
Description

Viatris generates revenue through the sale of pharmaceutical products including brand-name medicines, generic drugs, over-the-counter products, vaccines, and biosimilars. The company maintains a diversified portfolio of more than 400 brand products distributed through pharmacy channels.

viatris.de
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

MEDA Pharma manufactures and distributes a diversified portfolio of more than 400 branded pharmaceutical products in Germany, including prescription (Rx) and generic (Gx) medicines, over-the-counter (OTC) products, vaccines, biosimilars, homeopathic remedies, cosmetics, dietary supplements, and medical devices. Production is handled by the subsidiary Madaus GmbH in Troisdorf, and products reach patients via German pharmacies.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

MEDA Pharma is part of the Viatris Group in Germany and operates as a pharmaceutical company offering a broad portfolio of over 400 branded products. The product portfolio includes Arzneimittel (prescription and generic medicines), Homöopathika (homeopathic products), Kosmetik/Nahrungsergänzungsmittel/Medizinprodukte (cosmetics, dietary supplements, medical devices), as well as Vaccines, Biosimilars, and OTC products. Production is handled through subsidiary Madaus GmbH at the Troisdorf facility. The company is ranked among the Top 15 pharmaceutical providers in Germany, with approximately 1,000 employees in Germany and a global network of around 40 manufacturing sites.

Product and service1 record
1Arzneimittel (Pharmaceuticals)
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Madaus GmbH is part of the Viatris Group in Germany. It is a mid-sized pharmaceutical company with over 100 years of tradition, operating a production site in Troisdorf with approximately 300 employees. The company handles production, quality management, supply chain, finance, and human resources.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeBroad incumbent
Description

Global generics and biosimilars company spun out of Novartis, with major operations in Germany via Hexal. Direct overlap with MEDA Pharma's generic and biosimilar portfolio and German pharmacy channel.

TypeDirect peer
Description

German pharmaceutical manufacturer specializing in branded generics, OTC, and dermatology products distributed via German pharmacies. Comparable portfolio mix and distribution alignment with MEDA Pharma.

TypeDirect peer
Description

German generic pharmaceutical brand under Teva, distributing prescription and OTC generics across German pharmacies. Closely comparable portfolio and channel overlap with MEDA Pharma's generic and OTC offerings.

TypeDirect peer
Description

German-headquartered pharmaceutical company focused on generics, specialty pharma, and consumer healthcare (OTC). Highly comparable to MEDA Pharma given overlapping German footprint, mixed Rx/Gx/OTC portfolio, and pharmacy-led distribution model.

TypeBroad incumbent
Description

Global generics leader with strong presence in Europe including Germany through ratiopharm. Competes with MEDA Pharma across generic and biosimilar categories via similar pharmacy distribution channels.

TypeBroad incumbent
Description

German subsidiary of global pharma major Sanofi, distributing prescription medicines, vaccines, and consumer health products via German pharmacies. Overlaps with MEDA Pharma's Rx, vaccines, and OTC portfolio.

TypeDirect peer
Description

German OTC and consumer healthcare company with a portfolio of branded pharmacy products including homeopathic lines. Highly comparable on OTC, homeopathic, and pharmacy-led distribution overlap with MEDA Pharma.

TypeBroad incumbent
Description

Global life sciences company headquartered in Germany with a diversified pharmaceutical segment spanning prescription, specialty, and consumer health. Overlaps with MEDA Pharma on Rx and OTC distribution in Germany, but operates at a much larger global scale.

TypeDirect peer
Description

One of Germany's largest generic manufacturers and a Sandoz/Novartis subsidiary. Directly competes with MEDA Pharma on generic prescription medicines distributed through German pharmacies with a similar portfolio breadth.

TypeRegional player
Description

European-focused generics manufacturer headquartered in Czechia with significant DACH-region activity. Comparable business model around generics and OTC through European pharmacy distribution.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MEDA Pharma

Pharmaceutical Manufacturingmedapharma.de

MEDA Pharma firmographics

Firmographics
Name
MEDA Pharma
Legal name
MEDA Pharma GmbH & Co.KG
Website
https://medapharma.de
Company type
Private
Founded year
1919
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

MEDA Pharma industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414), Pharmacies and Drug Retailers (456110), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)
akta.pro primary industry
Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
akta.pro secondary industries
Generic Hospital & Institutional Products (HLAIABAL), Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC), Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)

Keywords

  • Pharmaceutical products
  • Prescription medicines
  • Generic drugs
  • Over-the-counter medicines
  • Vaccines biosimilars

Where MEDA Pharma is headquartered

Location

Headquarters

HQ city
Bad Homburg
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

MEDA Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

  1. Pharmaceutical Product Sales: Viatris generates revenue through the sale of pharmaceutical products including brand-name medicines, generic drugs, over-the-counter products, vaccines, and biosimilars. The company maintains a diversified portfolio of more than 400 brand products distributed through pharmacy channels.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

MEDA Pharma product offering

Product offering

Core offering

MEDA Pharma manufactures and distributes a diversified portfolio of more than 400 branded pharmaceutical products in Germany, including prescription (Rx) and generic (Gx) medicines, over-the-counter (OTC) products, vaccines, biosimilars, homeopathic remedies, cosmetics, dietary supplements, and medical devices. Production is handled by the subsidiary Madaus GmbH in Troisdorf, and products reach patients via German pharmacies.

Product overview

MEDA Pharma is part of the Viatris Group in Germany and operates as a pharmaceutical company offering a broad portfolio of over 400 branded products. The product portfolio includes Arzneimittel (prescription and generic medicines), Homöopathika (homeopathic products), Kosmetik/Nahrungsergänzungsmittel/Medizinprodukte (cosmetics, dietary supplements, medical devices), as well as Vaccines, Biosimilars, and OTC products. Production is handled through subsidiary Madaus GmbH at the Troisdorf facility. The company is ranked among the Top 15 pharmaceutical providers in Germany, with approximately 1,000 employees in Germany and a global network of around 40 manufacturing sites.

Differentiator

Problem solved

Functional benefit

Products and services

  • Arzneimittel (Pharmaceuticals)

Companies that use MEDA Pharma

Customer profile

Segments3 records

Ideal customer profiles2 records

MEDA Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

MEDA Pharma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Madaus GmbHcoreOthersMadaus GmbH is part of the Viatris Group in Germany. It is a mid-sized pharmaceutical company with over 100 years of tradition, operating a production site in Troisdorf with approximately 300 employees. The company handles production, quality management, supply chain, finance, and human resources.

Scale indicators5 records

Recent moves4 records

MEDA Pharma competitors and assessment

Company assessment

Broad incumbents

  • Sandoz Group AG: Global generics and biosimilars company spun out of Novartis, with major operations in Germany via Hexal. Direct overlap with MEDA Pharma's generic and biosimilar portfolio and German pharmacy channel.
  • Teva Pharmaceutical Industries: Global generics leader with strong presence in Europe including Germany through ratiopharm. Competes with MEDA Pharma across generic and biosimilar categories via similar pharmacy distribution channels.
  • Sanofi-Aventis Deutschland GmbH: German subsidiary of global pharma major Sanofi, distributing prescription medicines, vaccines, and consumer health products via German pharmacies. Overlaps with MEDA Pharma's Rx, vaccines, and OTC portfolio.
  • Bayer AG (Pharmaceuticals): Global life sciences company headquartered in Germany with a diversified pharmaceutical segment spanning prescription, specialty, and consumer health. Overlaps with MEDA Pharma on Rx and OTC distribution in Germany, but operates at a much larger global scale.

Direct peers

  • Dermapharm Holding SE: German pharmaceutical manufacturer specializing in branded generics, OTC, and dermatology products distributed via German pharmacies. Comparable portfolio mix and distribution alignment with MEDA Pharma.
  • ratiopharm GmbH: German generic pharmaceutical brand under Teva, distributing prescription and OTC generics across German pharmacies. Closely comparable portfolio and channel overlap with MEDA Pharma's generic and OTC offerings.
  • Stada Arzneimittel AG: German-headquartered pharmaceutical company focused on generics, specialty pharma, and consumer healthcare (OTC). Highly comparable to MEDA Pharma given overlapping German footprint, mixed Rx/Gx/OTC portfolio, and pharmacy-led distribution model.
  • Klosterfrau Berlin GmbH: German OTC and consumer healthcare company with a portfolio of branded pharmacy products including homeopathic lines. Highly comparable on OTC, homeopathic, and pharmacy-led distribution overlap with MEDA Pharma.
  • Hexal AG: One of Germany's largest generic manufacturers and a Sandoz/Novartis subsidiary. Directly competes with MEDA Pharma on generic prescription medicines distributed through German pharmacies with a similar portfolio breadth.

Regional players

  • Zentiva Group: European-focused generics manufacturer headquartered in Czechia with significant DACH-region activity. Comparable business model around generics and OTC through European pharmacy distribution.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

MEDA Pharma social profiles

Digital presence

MEDA Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MEDA Pharma leadership team

Management profile

Number of profiles

MEDA Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MEDA Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MEDA Pharma

What does MEDA Pharma do?

MEDA Pharma manufactures and distributes a diversified portfolio of more than 400 branded pharmaceutical products in Germany, including prescription (Rx) and generic (Gx) medicines, over-the-counter (OTC) products, vaccines, biosimilars, homeopathic remedies, cosmetics, dietary supplements, and medical devices. Production is handled by the subsidiary Madaus GmbH in Troisdorf, and products reach patients via German pharmacies.

Is MEDA Pharma a public or private company?

MEDA Pharma is a private company. It is classified as corporate owned and is currently operating.

When was MEDA Pharma founded?

MEDA Pharma was founded in 1919. It employs 51 to 100 people.

Where is MEDA Pharma based?

MEDA Pharma is headquartered in Bad Homburg, Germany, in the Europe region.

How does MEDA Pharma make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are MEDA Pharma's main competitors?

Broad incumbents on record are Sandoz Group AG, Teva Pharmaceutical Industries, Sanofi-Aventis Deutschland GmbH and Bayer AG (Pharmaceuticals). Direct peers are Dermapharm Holding SE, ratiopharm GmbH, Stada Arzneimittel AG, Klosterfrau Berlin GmbH and Hexal AG. Zentiva Group is listed as a regional player.

Does MEDA Pharma have an API?

No public API is recorded for MEDA Pharma.

What industry is MEDA Pharma in?

MEDA Pharma's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIABAL, Generic Hospital & Institutional Products. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales